Sophia Randolph
Chief Tech/Sci/R&D Officer at ALX ONCOLOGY HOLDINGS INC.
Net worth: 4 M $ as of 30/03/2024
Profile
Sophia Randolph is currently the Director & Chief Medical Officer at ALX Oncology Holdings, Inc. She previously worked as the Director-Clinical Sciences & Oncology at Merck & Co., Inc. from 2007 to 2008 and as the Executive Director-Oncology at Pfizer Inc. from 2015 to 2016.
Dr. Randolph completed her undergraduate degree at Harvard University and obtained a doctorate from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/02/2024 | 342,349 ( 0.68% ) | 4 M $ | 30/03/2024 |
Sophia Randolph active positions
| Companies | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 31/05/2016 |
Former positions of Sophia Randolph
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 31/03/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 30/04/2008 |
Training of Sophia Randolph
| Harvard University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
- Stock Market
- Insiders
- Sophia Randolph
